Members of the Exchange are hereby informed that the admission to dealings in securities of the company Sterling Biotech Limited shall be withdrawn (delisted) w.e.f. March 03, 2023 pursuant to Hon...

Sterling Biotech Ltd. manufactures gelatin.  The Company produces pharmaceutical- and neutraceutical-grade gelatin, and sells a biproduct called dicalcium phosphate to poultry feed manufacturers.  Sterling Biotech also produces coenzyme Q-10, a dietary supplement.

Delisting

Sterling Biotech Limited has informed the Exchange about Liquidation...

Liquidation

Sterling Biotech Limited has informed the Exchange about Corporate Insolvency Resolution Process......

Corporate Insolvency Resolution Process

Please find attached herewith Audited Financial Statement for the financial year 2020-21 of Sterling Biotech Limited along with Auditors Report.......

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00